Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 210

1.

Association of Aspirin Therapy with Risk of Hepatocellular Carcinoma: a systematic review and dose-response analysis of cohort studies with 2.5 million participants.

Wang S, Yu Y, Ryan PM, Dang M, Clark C, Kontogiannis V, Rahmani J, Varkaneh HK, Salehisahlabadi A, Day AS, Zhang Y.

Pharmacol Res. 2019 Dec 6:104585. doi: 10.1016/j.phrs.2019.104585. [Epub ahead of print] Review.

PMID:
31816436
2.

Re: A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome.

Appleton L, Day AS.

J Clin Med. 2019 Nov 6;8(11). pii: E1885. doi: 10.3390/jcm8111885.

3.

In Reply to (Meta-analysis on obesity and risk of inflammatory bowel disease: re-analysis is needed).

Rahmani J, Kord Varkaneh H, Hekmatdoost A, Thompson J, Clark C, Salehisahlabadi A, Day AS, Jacobson K.

Obes Rev. 2020 Jan;21(1):e12956. doi: 10.1111/obr.12956. Epub 2019 Nov 5. No abstract available.

PMID:
31691435
4.

Healthy Eating Index-2015 as a predictor of ulcerative colitis risk in a case-control cohort.

Rahmani J, Varkaneh HK, Ryan PM, Zarezadeh M, Rashvand S, Clark C, Day AS, Hekmatdoost A.

J Dig Dis. 2019 Dec;20(12):649-655. doi: 10.1111/1751-2980.12826. Epub 2019 Nov 21.

PMID:
31634419
5.

To Be Oats or Not to Be? An Update on the Ongoing Debate on Oats for Patients With Celiac Disease.

Spector Cohen I, Day AS, Shaoul R.

Front Pediatr. 2019 Sep 26;7:384. doi: 10.3389/fped.2019.00384. eCollection 2019. Review.

6.

Re: Parental Education May Differentially Modulate Pediatric Inflammatory Bowel Disease Phenotype Risk.

Day AS.

Inflamm Bowel Dis. 2019 Oct 6. pii: izz235. doi: 10.1093/ibd/izz235. [Epub ahead of print] No abstract available.

PMID:
31587055
7.

Dietary total antioxidant capacity and risk of ulcerative colitis: A case-control study.

Rahmani J, Kord-Varkaneh H, Ryan PM, Rashvand S, Clark C, Day AS, Hekmatdoost A.

J Dig Dis. 2019 Dec;20(12):636-641. doi: 10.1111/1751-2980.12823. Epub 2019 Nov 14.

PMID:
31571400
8.

An Overview of Inflammatory Bowel Disease Unclassified in Children.

Thurgate LE, Lemberg DA, Day AS, Leach ST.

Inflamm Intest Dis. 2019 Aug;4(3):97-103. doi: 10.1159/000501519. Epub 2019 Jul 19. Review.

9.

Editorial: the reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food reintroduction.

Wall CL, Day AS.

Aliment Pharmacol Ther. 2019 Oct;50(7):824-825. doi: 10.1111/apt.15475. No abstract available.

PMID:
31532560
10.

The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases.

Ho SSC, Keenan JI, Day AS.

Dig Dis Sci. 2019 Sep 16. doi: 10.1007/s10620-019-05841-x. [Epub ahead of print] Review.

PMID:
31529416
11.

Nutritional regulators of intestinal inflammation.

Shaoul R, Day AS.

Curr Opin Gastroenterol. 2019 Nov;35(6):486-490. doi: 10.1097/MOG.0000000000000585.

PMID:
31464809
12.

Diagnosis and management of children with Blue Rubber Bleb Nevus Syndrome: A multi-center case series.

Isoldi S, Belsha D, Yeop I, Uc A, Zevit N, Mamula P, Loizides AM, Tabbers M, Cameron D, Day AS, Abu-El-Haija M, Chongsrisawat V, Briars G, Lindley KJ, Koeglmeier J, Shah N, Harper J, Syed SB, Thomson M.

Dig Liver Dis. 2019 Nov;51(11):1537-1546. doi: 10.1016/j.dld.2019.04.020. Epub 2019 Jul 26.

PMID:
31358484
13.

The impact of exclusive enteral nutrition on the intestinal microbiota in inflammatory bowel disease.

Day AS.

AIMS Microbiol. 2018 Jul 20;4(4):584-593. doi: 10.3934/microbiol.2018.4.584. eCollection 2018. Review.

14.

Response pattern analysis of IBD-KID: A knowledge assessment tool for children with inflammatory bowel disease.

Vernon-Roberts A, Otley A, Frampton C, Gearry RB, Day AS.

J Paediatr Child Health. 2019 Jun 26. doi: 10.1111/jpc.14547. [Epub ahead of print]

PMID:
31243856
15.

Body mass index and risk of inflammatory bowel disease: A systematic review and dose-response meta-analysis of cohort studies of over a million participants.

Rahmani J, Kord-Varkaneh H, Hekmatdoost A, Thompson J, Clark C, Salehisahlabadi A, Day AS, Jacobson K.

Obes Rev. 2019 Sep;20(9):1312-1320. doi: 10.1111/obr.12875. Epub 2019 Jun 12. Review.

PMID:
31190427
16.

Newly Diagnosed Crohn's Disease Treated with Standard Care or Enteral Nutrition: Psychological Outcomes over 6 Months.

Wall CL, McCombie AM, Gearry RB, Day AS.

Inflamm Intest Dis. 2019 May;4(1):7-13. doi: 10.1159/000497323. Epub 2019 Mar 20.

17.

Exclusive enteral nutrition in children with inflammatory bowel disease: Physician perspectives and practice.

Ho SSC, Day AS.

JGH Open. 2018 Dec 12;3(2):148-153. doi: 10.1002/jgh3.12121. eCollection 2019 Apr.

18.

A Symptom Self-report Tool for Children With Inflammatory Bowel Disease (IBDnow).

Vernon-Roberts A, Lopez RN, Frampton C, Gearry RB, Lemberg DA, Day AS.

J Pediatr Gastroenterol Nutr. 2019 Jul;69(1):e7-e12. doi: 10.1097/MPG.0000000000002329.

PMID:
30921259
19.

Letter: low FODMAP diet-directions for future research.

O'Brien L, Brown S, Gearry RB, Day AS.

Aliment Pharmacol Ther. 2019 Apr;49(8):1107-1108. doi: 10.1111/apt.15175. No abstract available.

PMID:
30920042
20.

Letter to the Editor Re: Serum Calprotectin in Adolescents With Inflammatory Bowel Disease.

Day AS, Ho SSC, Leach ST.

J Pediatr Gastroenterol Nutr. 2019 Jun;68(6):e109. doi: 10.1097/MPG.0000000000002345. No abstract available.

PMID:
30908387

Supplemental Content

Loading ...
Support Center